Neurocognitive Impairment in Long COVID: A Systematic Review
Archives of Clinical Neuropsychology · 21.01.2025 · 40 (1) · 125-149
DOI: 10.1093/arclin/acae042 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Clinical Neuropsychology, online erschienen am 08.06.2024. Verfasst von Eugenia Panagea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropsychology and Behavioral Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: COVID-19, Cognitive Dysfunction. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory infectious disease, it has also been associated with a wide range of other clinical manifestations. It is widely accepted in the scientific community that many patients after recovery continue to experience COVID-19-related symptoms, including cognitive impairment. The aim of this systematic review was to investigate the cognitive profile of patients with long-COVID syndrome.
Methods
A systematic search of empirical studies was conducted through the PubMed/Medline and Scopus electronic databases. Cross-sectional and longitudinal studies published between 2020 and 2023 were included.
Results
Of the 516 studies assessed for eligibility, 36 studies met the inclusion criteria. All included studies support the presence of persistent cognitive changes after COVID-19 disease. Executive function, memory, attention, and processing speed appear to be the cognitive domains that are predominantly associated with long-COVID syndrome, whereas language is an area that has not been sufficiently investigated.
Conclusions
In this review, the high frequency of cognitive impairment after COVID-19 is evident. If we consider that cognitive functioning affects our ability to live independently and is a key determinant of our quality of life, it is imperative to precisely define those factors that may induce cognitive impairment in COVID-19 survivors, with the ultimate goal of early diagnosis of cognitive changes and, consequently, the development of targeted rehabilitation interventions to address them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neuropsychology and Behavioral Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Department of Psychiatry, University of Patras Medical School, Patras, Greece.
- Department of Neurology, Laboratory of Neurogenetics, University of Thessaly, University Hospital of Larissa, Larissa, Greece.
- Department of Speech and Language Therapy, University of Ioannina, Ioannina, Greece.
ORCID-Profile: Lambros Messinis
Zitieren
APA
Panagea, E., Messinis, L., Petri, M. C., Liampas, I., Anyfantis, E., Nasios, G., Patrikelis, P., & Kosmidis, M. (2025). Neurocognitive Impairment in Long COVID: A Systematic Review. Archives of Clinical Neuropsychology, 40(1), 125-149. https://doi.org/10.1093/arclin/acae042
Vancouver
Panagea E, Messinis L, Petri MC, Liampas I, Anyfantis E, Nasios G, et al. Neurocognitive Impairment in Long COVID: A Systematic Review. Archives of Clinical Neuropsychology. 2025;40(1):125-149. doi:10.1093/arclin/acae042
BibTeX
@article{Panagea2025,
author = {Panagea, Eugenia and Messinis, Lambros and Petri, Maria Christina and Liampas, Ioannis and Anyfantis, Emmanouil and Nasios, Grigorios and Patrikelis, Panayiotis and Kosmidis, Mary},
title = {Neurocognitive Impairment in Long COVID: A Systematic Review},
journal = {Archives of Clinical Neuropsychology},
year = {2025},
volume = {40},
number = {1},
pages = {125--149},
doi = {10.1093/arclin/acae042}
}
EUVIMED